Search clinical trials for: SB-913

Total 1178 results

GlaxoSmithKline

Completed

Bioequivalence and Food Effect Study in Healthy Volunteers

Sleep Initiation and Maintenance Disorders

Italy
GlaxoSmithKline

Completed

A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18

Lymphoma, Non-Hodgkin

United States
GlaxoSmithKline

Completed

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

Solid Tumor Cancer

United Kingdom
Proviva Therapeutics, Inc.

Not yet recruiting

A First-in-human (FIH), Multicenter, Open-Label, Phase I Study of PTX-912 in Patients With Locally Advanced/Metastatic Solid Tumors

Solid Tumor | Metastatic Cancer | Advanced Cancer
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

Healthy

Japan
argenx

Completed

A Study to Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects

Bioavailability Study

Netherlands
Suven Life Sciences Limited

Completed

Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects (SUVN-911)

Major Depressive Disorder

United States
Wake Forest University Health Sciences

Completed

Study to Evaluate Safety, Tolerability, Maximum Tolerated Dose (MTD), Efficacy, and Pharmacokinetics (PKs) of CPI-613 Given Twice Weekly for Three Consecutive Weeks in Patients With Advanced Hematologic Malignancies

Advanced Hematologic Malignancies

United States
Cornerstone Pharmaceuticals

Completed

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Lymphoma | Metastatic Cancer | Advanced Cancer | Solid Tumors | Advanced Malignancies

United States, Canada
Avanir Pharmaceuticals

Completed

Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients

Multiple Sclerosis

United States
Cliniques universitaires Saint-Luc- Université...

Unknown

Investigating Project of the Functional C13 Test "Pilot Study" (PIL001)

Disorder of the Urea Cycle

Belgium
Walid HABRE

Completed

PSV on Ventilation Inhomogeneity and Lung Function in Patients Under SB Across LMA (VINHO)

Anesthesia, General | Ventilation | Respiratory Function Tests | Patient Positioning

Switzerland
AbbVie

Completed

A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Participants

Healthy Volunteer

United States
Hôpital Européen Marseille
Aix Marseille Université

Terminated

Response of the Autonomic Nervous System to Auricular Stimulation of the Vagus Nerve (x) (AURIX)

Vasoconstriction Disorder of Extremities

France
Mitsubishi Tanabe Pharma Corporation

Completed

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Medical College of Wisconsin

Not yet recruiting

Puerto Rican Obesity Intervention for Men

Obesity

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Massachusetts General Hospital; City of Hope Medical... and other collaborators

Active, not recruiting

A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations

Lymphoma | Leukemia

United States
Amgen

Terminated

Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric and Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Colorectal Cancer | Esophageal Neoplasms | Metastatic Pancreatic Cancer | Carcinoma, Non-small-cell Lung

United States, Japan
Trygg Pharma, Inc.

Unknown

Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia

Severe Hypertriglyceridemia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating CMD-193 in Advanced Malignant Solid Tumors

Neoplasms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors

Neoplasms

Japan
AbbVie

Not yet recruiting

A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult Volunteers

Healthy Volunteers
Ono Pharmaceutical Co. Ltd

Completed

ONO-7913 Phase I Study (ONO-7913)

Solid Tumor

Japan
Sichuan Clover Biopharmaceuticals, Inc.

Completed

A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion

Malignant Pleural Effusion

China
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors

Nonhematologic Neoplasms, Advanced

Japan
Takeda

Completed

Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study

Healthy Volunteers

United States
Javier Villaneuva-Meyer, MD
National Institute for Biomedical Imaging and Bioengineering (NIBIB); General...

Recruiting

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

Meningioma

United States
Hutchmed

Active, not recruiting

A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors, Colorectal, and Breast Cancer

Rectal Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Colon Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer

United States
Amgen

Recruiting

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

MTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid Tumors

United States, Australia
Vaxxinity, Inc.

Recruiting

A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants

Migraine

Belgium
Suven Life Sciences Limited

Active, not recruiting

Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

Major Depressive Disorder

United States
Q32 Bio Inc.
Innovaderm Research Inc.

Active, not recruiting

Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Alopecia Areata

United States
Hutchmed

Completed

Fruquintinib Renal Impairment Study

Renal Impairment

United States
argenx
Quintiles, Inc.

Completed

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

Primary Immune Thrombocytopenia

Austria, Belgium, France, Germany, Spain, Czechia, Hungary, Poland, Ukraine, United Kingdom
argenx

Active, not recruiting

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). (ADVANCE+)

Primary Immune Thrombocytopenia

United States, Austria, Belgium, Bulgaria, Czechia, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom, Ukraine
Takeda

Completed

A Study of TAK-919 in Healthy Japanese Adults (COVID-19)

Coronavirus Disease (COVID-19)

Japan
Hutchmed

Completed

Fruquintinib Hepatic Impairment Study

Hepatic Impairment

United States
Otonomy, Inc.

Completed

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

Sensorineural Hearing Loss

United States
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Terminated

Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients

Healthy
BIO-CAT Microbials, LLC
KGK Science Inc.

Completed

A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride

Elevated Triglycerides

Canada
Seikagaku Corporation
Chiltern International Inc.

Completed

SI-613 Study for Knee Osteoarthritis

Osteoarthritis, Knee

United States
Johns Hopkins University

Terminated

Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States

Schizophrenia | Bipolar Disorder

United States
Kaken Pharmaceutical
Dow Pharmaceutical Sciences

Completed

A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

Atopic Dermatitis

United States
GlaxoSmithKline

Terminated

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Osteoporosis

Germany, Russian Federation, Korea, Republic of, United States, Belgium, Hong Kong, Spain, Australia, Argentina, South Africa, Poland, Norway, Mexico, Denmark
Vertex Pharmaceuticals Incorporated

Active, not recruiting

A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics, of VX-993

Pain

United States
argenx

Completed

IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers

Healthy Volunteers
M.D. Anderson Cancer Center

Active, not recruiting

A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

Lymphomas | B-cell Lymphomas

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 1 Dose Escalation Study of VX-993 in Healthy Participants

Pain

United Kingdom
Novartis Pharmaceuticals

Terminated

Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants

Healthy Volunteers

United Kingdom

Search clinical trials for: SB-913

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations